PharmaEssentia Corporation
6446
Kedudukan dalam Saham
#1439
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Harga Saham
$36.89
Modal Pasaran
$15.25B
Perubahan (1 hari)
-1.28%
Perubahan (1 tahun)
144.12%
Negara
TW
Perdagangan PharmaEssentia Corporation (6446)
Kategori
Healthcare
Sejarah pecahan saham untuk PharmaEssentia Corporation (6446)
Saham PharmaEssentia Corporation (simbol: 6446) telah mengalami sejumlah 2 pecahan saham.
Pecahan saham terkini berlaku pada Jul 09, 2026.
Satu saham 6446 yang dibeli sebelum Sep 11, 2025 kini bersamaan dengan 1.229881 saham 6446.
Pecahan saham terkini berlaku pada Jul 09, 2026.
Satu saham 6446 yang dibeli sebelum Sep 11, 2025 kini bersamaan dengan 1.229881 saham 6446.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2026-07-09 | 1109:1000 | x1.109 | x1.229881 |
| 2025-09-11 | 1109:1000 | x1.109 | x1.109 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
